Bibliographie
Les membres du personnel de l’EDQM présentant un haut niveau de qualification contribuent régulièrement à des articles scientifiques publiés dans diverses revues. La liste ci-dessous répertorie tous ceux parus au cours de l’année 2024.
Publications externes
- Henman M. C., Ravera S., Lery F.-X. (2024), “Council of Europe Resolution on the implementation of pharmaceutical care – A step forward in enhancing the appropriate use of medicines and patient-centred care”, Healthcare, 2024 12(2): 232.
- Martin D. E., Van Assche K., Cervantes L. et al. (2024), “Toward Equity in Global Access to SoHO-based Therapies: Recommendations for Action”, Transplantation 109(1): 60-72.
- Sajjadi N. C., Brady R., Jungbäck C. et al. (2024), “Maintaining the quality of vaccines through the use of standards: Current challenges and future opportunities”, Biologicals, May 2024(86):101756.
- Abend A., Stippler E., Kühl N. et al. (2024), “Commentary on ‘The effect of sampling cannula on in vitro dissolution testing with USP paddle method’”, The AAPS Journal, 2024(26) 73,
- Martin D. E., Capron A. M., Fadhil, R. A. S. et al. (2024), “Supporting Financial Neutrality in Donation of Organs, Cells, and Tissues”, Transplantation 109(1): 48-59.
- Martin D. E., Capron A. M., Fadhil R. A. S. et al. (2024), “Prevention of trafficking in organs, tissues, and cells”, Transplantation 109(1): 88-97.
- Domínguez-Gil B., López-Fraga M., Muller E. et al. (2024), “Santander Global Summit in Transplantation: Supporting Global Convergence in the Shared Goals of Sufficiency, Transparency, and Oversight”, Transplantation 109(1).
- Peghin M., Graziano E., Martino M. De et al. (2024), “Acceptance of organs from deceased donors with resolved or active SARS-CoV-2 infection: A survey from the Council of Europe”, Transplant International, 2024(37).
Pharmeuropa Bio & Scientific Notes
Pharmeuropa Bio & Scientific Notes a pour objectif de diffuser des connaissances sur les méthodes d’analyse applicables au contrôle qualité pharmaceutique, en particulier les résultats obtenus pour les produits pharmaceutiques. Cette revue contient des articles scientifiques relatifs à la standardisation biologique, qui mettent principalement l’accent sur le Programme de standardisation biologique de l’EDQM et sur les travaux de la Pharmacopée Européenne (Ph. Eur.). Elle comporte également des rapports d’établissement d’étalons de référence clés de la Ph. Eur. (PBR/SCR/RBR) pour les produits biologiques.
Tous les articles publiés dans Pharmeuropa Bio & Scientific Notes en 2024 sont disponibles à l’adresse: https://pbiosn.edqm.eu/app/pbiosn/search?chapter=201055&title=2024.
- Stickings P., Tierney R., Hockley J. et al. (2024), “Collaborative study for the establishment of Ph. Eur. Biological Reference Preparation for Human tetanus immunoglobulin batch 2”, Pharmeur Bio Sci Notes, 2024:1-11.
- Bratos M., Kolaj-Robin O., Antoni M. et al. (2024), “Ph. Eur. testing for histamine and depressor substances using guinea-pigs and cats: the end of an era – Strategy for removal of animal tests for histamine and depressor substances and their vestiges from the Ph. Eur.”, Pharmeur Bio Sci Notes, 2024:12-26.
- Behr-Gross M-E., Le Tallec D., Sinitskaya N. et al. (2024), “Determination of procoagulant activity in human normal immunoglobulin preparations for therapeutic use by FXIa chromogenic assay: Evaluation of test kit sensitivity, reference standard performance and product formulation effects on the FXIa assay”, Pharmeur Bio Sci Notes, 2024:27-75.
- Thorpe SJ., Virata ML., Fox B. et al. (2024), “International collaborative study to assess new stocks of candidate reference preparations to control the level of anti-D in IVIG”, Pharmeur Bio Sci Notes, 2024:76-89.
- Jouette S. and Regourd E. (2024), “Collaborative study for the establishment of Human immunoglobulin (molecular size) BRP replacement batches 4, 5 and 6”, Pharmeur Bio Sci Notes, 2024: 90-105.
- Fox B., Regourd E., Rigsby P. et al. (2024), “Joint WHO/EDQM Collaborative study for the establishment of WHO 3rd International Standard and Ph. Eur. Biological Reference Preparation for Prekallikrein activator in albumin batch 7”, Pharmeur Bio Sci Notes, 2024: 106-126.
- Behrensdorf-Nicol H., Krämer B., Le Tallec D. et al. (2024), “Collaborative study for the characterisation of the BINACLE Assay for in vitro detection of tetanus toxicity in toxoids – Part 1”, Pharmeur Bio Sci Notes, 2024: 127-161.
- Behrensdorf-Nicol H., Le Tallec D., Sinitskaya N. et al. (2024), “Collaborative study for the characterisation of the BINACLE Assay for in vitro detection of tetanus toxicity in toxoids – Part 2”, Pharmeur Bio Sci Notes, 2024: 162-192.
- Kefeder C., Eichmeir S., Le Tallec D. et al. (2024), “Collaborative Study for the Calibration of the Ph.Eur. Prekallikrein Activator in Albumin Biological Reference Preparation batches 8, 9 and 10”, Pharmeur Bio Sci Notes, 2024: 193-220.
- Costanzo A., Regourd E., Ridoux V. (2024), “Validation of an ELISA method for determination of physical particle titre of AAV2-based vector preparations”, Pharmeur Bio Sci Notes, 2024: 221-233.
- Wadhwa M., Rigsby P., Behr-Gross M-E. (2024), “Collaborative study for the establishment of Golimumab Biological Reference Preparation Batch 1”, Pharmeur Bio Sci Notes, 2024: 234-239
- Morgeaux S., Manniam I., Le Tallec D. et al. (2024), “Establishment of hepatitis A virus coating reagent batch 2 for in vitro potency assay of hepatitis A vaccines by ELISA”, Pharmeur Bio Sci Notes, 2024: 240-250.
- Cowper B., Le Tallec D., Costanzo A. (2024), “Establishment of Erythropoietin for physicochemical tests CRS batch 2”, Pharmeur Bio Sci Notes, 2024: 251-274.
